Generally revise laws related to prior authorization for psychiatric medications related to schizophrenia

Bill LC 3271 aimed to revise state laws requiring insurance approval (prior authorization) for psychiatric medications used to treat schizophrenia. The proposed changes would have simplified or streamlined this process, directly affecting patients with schizophrenia and healthcare providers seeking to prescribe these medications. However, the bill did not advance beyond the drafting stage, as it was assigned a drafter in December 2024 but died in process in May 2025 without becoming law. No concrete policy changes were implemented through this legislation.